MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 25 filers reported holding MOLECULIN BIOTECH INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $756,000 | +4.4% | 948,503 | +6.4% | 0.00% | 0.0% |
| Q3 2020 | $724,000 | -45.3% | 891,141 | -34.8% | 0.00% | 0.0% |
| Q2 2020 | $1,323,000 | +71.8% | 1,367,525 | +8.2% | 0.00% | 0.0% |
| Q1 2020 | $770,000 | -16.5% | 1,263,925 | +25.5% | 0.00% | 0.0% |
| Q4 2019 | $922,000 | -11.2% | 1,007,364 | +7.7% | 0.00% | 0.0% |
| Q3 2019 | $1,038,000 | -0.4% | 935,264 | +12.2% | 0.00% | 0.0% |
| Q2 2019 | $1,042,000 | +720.5% | 833,664 | +430.4% | 0.00% | – |
| Q1 2019 | $127,000 | +195.3% | 157,164 | +279.0% | 0.00% | – |
| Q4 2018 | $43,000 | – | 41,464 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitegate Investment Counselors, Inc. | 101,781 | $81,000 | 0.01% |
| Levy Wealth Management Group, LLC | 14,036 | $11,000 | 0.01% |
| WOODMONT INVESTMENT COUNSEL LLC | 12,000 | $10,000 | 0.00% |
| Renaissance Technologies | 948,503 | $756,000 | 0.00% |
| Qube Research & Technologies Ltd | 132,238 | $105,000 | 0.00% |
| Core Wealth Advisors, Inc. | 1,711 | $1,000 | 0.00% |
| UBS Group AG | 36,726 | $29,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| Squarepoint Ops LLC | 12,342 | $10,000 | 0.00% |
| TRUE Private Wealth Advisors | 2,500 | $1,000 | 0.00% |